首页 › 基金 › DUMAC, INC. › SGMT
DUMAC, INC. 对 SGMT 的持仓历史
SAGIMET BIOSCIENCES INC COM SER A · 医疗保健
DUMAC, INC. 在 Q2 2026 的 13F 申报中披露持有 SGMT(SAGIMET BIOSCIENCES INC COM SER A)71,192 股,市值约 US$550K,约占其申报组合的 0.05%,在其申报持仓中市值排名第 14 位。 DUMAC, INC. 最近 12 个申报季度中有 10 个季度披露了 SGMT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
DUMAC, INC. 对 SGMT 的持仓演变
DUMAC, INC. 于 Q3 2023 首次披露 SGMT 持仓:204,123 股(约 US$1.8M)。 在 10 次申报中,DUMAC, INC. 0 次增持、5 次减持、4 次保持不变。 最近一期申报(Q2 2026)显示持股 71,192 股、市值约 US$550K。 持仓曾出现大幅变动:Q2 2025 减持约 49% (随后一个季度股价下跌 10%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 204.12K | $1.80M | 新进 |
| Q4 2023 | 204.12K | $1.11M | 持有 |
| Q1 2024 | 189.39K | $1.03M | 减持 |
| Q3 2024 | 189.39K | $524.62K | 持有 |
| Q4 2024 | 163.51K | $735.81K | 减持 |
| Q1 2025 | 147.35K | $480.36K | 减持 |
| Q2 2025 | 75.00K | $571.50K | 减持 |
| Q4 2025 | 71.19K | $421.46K | 减持 |
| Q1 2026 | 71.19K | $371.98K | 持有 |
| Q2 2026 | 71.19K | $550.31K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SGMT 与 13F 数据
SGMT(SAGIMET BIOSCIENCES INC COM SER A)属于医疗保健行业。我们追踪的基金中还有 59 只申报持有 SGMT,申报仓位最大的包括:SILVERARC CAPITAL MANAGEMENT, LLC (US$22.6M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SGMT 的基金
- SILVERARC CAPITAL MANAGEMENT, LLC 2.93M 股 · $22.63M · Q2 2026
- BVF INC/IL 2.50M 股 · $19.32M · Q2 2026
- Caligan Partners LP 2.50M 股 · $19.32M · Q2 2026
- Affinity Asset Advisors, LLC 2.50M 股 · $19.31M · Q2 2026
- GREAT POINT PARTNERS LLC 2.03M 股 · $15.69M · Q2 2026
- Saturn V Capital Management LP 1.48M 股 · $11.44M · Q2 2026
- Blue Owl Capital Holdings LP 1.26M 股 · $9.74M · Q2 2026
- 高瓴资本 724.80K 股 · $5.60M · Q2 2026
- Seven Fleet Capital Management LP 403.55K 股 · $3.12M · Q2 2026
- Palo Alto Investors LP 250.00K 股 · $1.93M · Q2 2026
- Pale Fire Capital SE 221.88K 股 · $1.72M · Q2 2026
- Sofinnova Investments, Inc. 166.67K 股 · $1.29M · Q2 2026
常见问题
How long has DUMAC, INC. held SGMT?
DUMAC, INC. has disclosed SGMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is DUMAC, INC.'s current position in SGMT?
As of Q2 2026, DUMAC, INC. holds 71.19K shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A), valued at $550.31K, representing 0.05% of its reported portfolio and ranking #14.
Has DUMAC, INC. been buying or selling SGMT?
In the latest 13F filing (Q2 2026), DUMAC, INC. held unchanged its position in SGMT.
Which other funds hold SGMT?
Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.